Form 4: Director John G. Stratton Receives Abbott Stock Grant

Abbott Laboratories director John G. Stratton was granted 2,286 restricted stock units under the 2026 Incentive Stock Program.

Summary

• Director John G. Stratton acquired 2,286 restricted stock units (RSUs) on April 24, 2026.
• The grant was issued under the Abbott Laboratories 2026 Incentive Stock Program.
• The RSUs are valued at $0 at the time of grant and will be settled in common shares on a one-to-one basis.
• Following this transaction, the director's total beneficial ownership of Abbott common shares is 21,319.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The grant aligns the director's long-term interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the RSU award is subject to future fluctuations in Abbott Laboratories' share price.

Future Outlook

The RSUs will vest and be paid out in common shares upon the director's separation from service, death, or a change in control of the company.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure alignment between leadership and shareholder interests in the healthcare sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices among large-cap S&P 500 healthcare companies.
• The vesting schedule tied to separation from service is a common retention and alignment mechanism for non-employee directors.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• The director will hold the RSUs until the occurrence of a triggering event such as separation from service.

Key Dates

Keywords

Abbott Laboratories, ABT, Form 4, Insider Trading, Director Compensation, Restricted Stock Units